logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
Expert Opinion on Drug Safety cover

Expert Opinion on Drug Safety

IF3.1
Papers2753
Citations5299
Journal Papers 2759
Publication Date
delete
Exploring the safety and efficacy of DOACs in clinically complex phenotypes of patients with atrial fibrillation: focus on frailty, multimorbidity and polypharmacy
deleteExpert Opinion on Drug Safety
IF3.1
delete2026-07-12
delete0
PREAI
deletePanteleimon E. Papakonstantinou; Gregory Y. H. Lip
deleteShare
deleteSave
Trigger tool methodologies in hospital settings: reappraising their role in pharmacovigilance and digital safety surveillance
deleteExpert Opinion on Drug Safety
IF3.1
delete2026-07-10
delete0
PREAI
deleteMarija Ilic; Dejana Krajacic; Marina Blagojevic; Milica Paut Kusturica; Jovanka Kolarovic; Djendji Siladji; Nebojsa Stilinovic; Aleksandar Raskovic
deleteShare
deleteSave
Could anticholinergics accelerate ALS progression? A critical perspective on drug safety and disease vulnerability
deleteExpert Opinion on Drug Safety
IF3.1
delete2026-06-30
delete0
PREAI
deleteTiffany R. Price; Chia-Yuan Chang; Kirya Skinner; Michael Dinneny; Parmida Nafezi; Lisa Kuramoto; Mary A. De Vera; Neil R. Cashman; Jacquelyn J. Cragg
deleteShare
deleteSave
A systematic review and meta-analysis of safety and efficacy parameters of sotatercept in the therapy of pulmonary arterial hypertension
deleteExpert Opinion on Drug Safety
IF3.1
delete2026-06-09
delete0
PREAI
deleteSiddhartha Dutta; Rima Shah; Shubha Singhal; Mamta Singh; Sagar Dholariya; Shalini Chawla; Chandan Katoch
deleteShare
deleteSave
Tirzepatide data: safety first is safety always!
deleteExpert Opinion on Drug Safety
IF3.1
delete2026-06-02
delete0
PREAI
deleteMiodrag Janić; Syed Arman Rabbani; Mohamed El-Tanani; Imran Rangraze; Andrej Janež; Viviana Maggio; Manfredi Rizzo
deleteShare
deleteSave
An update on the safety of biologics for the treatment of psoriasis
deleteExpert Opinion on Drug Safety
IF3.1
delete2026-05-22
delete0
PREAI
deleteVictoria McGuirt; Hiral Patel; Maia Davis; Steven Feldman
deleteShare
deleteSave
Recent advances in trastuzumab and its antibody-drug conjugates-related liver injury
deleteExpert Opinion on Drug Safety
IF3.1
delete2026-05-17
delete0
PREAI
deleteLiyi Chen; Guo-Hui Li; Chun-Yu Li
deleteShare
deleteSave
Long-term cardiotoxicity outcomes of trastuzumab and cardiac safety of novel HER2-targeted therapies
deleteExpert Opinion on Drug Safety
IF3.1
delete2026-05-04
delete0
PREAI
deleteSelin Akturk Esen; Dogan Uncu; Mehmet Ali Nahit Sendur
deleteShare
deleteSave
Safety of anti-IL-5 compounds for the treatment of eosinophilic asthma with a focus on special populations
deleteExpert Opinion on Drug Safety
IF3.1
delete2026-05-01
delete0
PREAI
deleteCaminati, Marco; Gagliani, Claudia; Bondi, Benedetta; Bagnasco, Diego; Vijverberg, Susanne J. H.; Zurlo, Marco; Maule, Matteo; Principe, Stefania
deleteShare
deleteSave
A novel, widespread impurity in mass-compounded tirzepatide/B12 products: potential patient safety implications
deleteExpert Opinion on Drug Safety
IF3.1
delete2026-04-30
delete0
PREAI
deleteBrad Jordan; Luke Arbogast; Matthew Clemens; Lihua Huang; Matthew Snyder
deleteShare
deleteSave
Safety of SGLT2 inhibitors for patients with type 2 diabetes: where are we now?
deleteExpert Opinion on Drug Safety
IF3.1
delete2026-04-30
delete0
PREAI
deleteAndré J. Scheen
deleteShare
deleteSave
Bridging evidence gaps in dravet syndrome: real-world safety insights from under-reported antiseizure therapies
deleteExpert Opinion on Drug Safety
IF3.1
delete2026-04-28
delete0
PREAI
deleteAlessandro Ferretti; Antonella Riva; Lorenzo Perilli; Pasquale Parisi; Pasquale Striano
deleteShare
deleteSave
Cardiorenometabolic medicine as a new subspecialty in the light of novel pharmaceuticals with dual or triple benefits
deleteExpert Opinion on Drug Safety
IF3.1
delete2026-04-23
delete0
PREAI
deleteSanja Medenica; Vladimir Prelević; Nikola Zanković; Viviana Maggio; Manfredi Rizzo
deleteShare
deleteSave
The efficacy and safety of antithrombotic drug options in acute ischemic stroke
deleteExpert Opinion on Drug Safety
IF3.1
delete2026-04-21
delete0
PREAI
deleteMichele Laudisi; Caterina Ferri; Maura Pugliatti; Maurizio Paciaroni
deleteShare
deleteSave
Safety concerns associated with various types of statins: a disproportionality analysis of the FAERS database
deleteExpert Opinion on Drug Safety
IF3.1
delete2026-04-20
delete0
PREAI
deleteYi Zeng; Xiaona Tian; Jiazhen Jiang; Wenhao Pan; Bingshuo Liu; Dandan Dai; Lisi Zhou; Wenling Zeng; Yizhen Chen; Jiaming Liu
deleteShare
deleteSave
Refractory immune-related adverse events (irAes) associated with immune checkpoint inhibitor therapy: a multiorgan management review
deleteExpert Opinion on Drug Safety
IF3.1
delete2026-04-19
delete0
PREAI
deleteMaria Julia Moura; Anirudha Chatterjee; Sharada Wali; Devin R. Garza; Hamza Salim; Jarrett Rong; Raakhi Menon; Faraz Jafri; Andres Urias Rivera; Rachel Mortan; Nicolas L. Palaskas; Kerry L. Reynolds; Rebecca K. Leaf; Nupur Kikani; Anusha Thomas; Hao Chi Zhang; Lan Sun Wang; Suddakar Tummala; Nagham Al-Zubidi; Ajay Sheshadri; Ala Abudayyeh; Yuanteng Li Jeff; Yinghong Wang
deleteShare
deleteSave
Long-term safety and effectiveness of vonoprazan as maintenance therapy for reflux esophagitis in Japan: a 12-month post-marketing surveillance study
deleteExpert Opinion on Drug Safety
IF3.1
delete2026-04-15
delete0
PREAI
deleteNoriaki Manabe; Masako Matsuo; Chihiro Suzuki
deleteShare
deleteSave
Safety and efficacy of currently used drug therapies for treatment of lymphomas in patients with Sjögren’s disease, a scoping review
deleteExpert Opinion on Drug Safety
IF3.1
delete2026-04-10
delete0
PREAI
deleteMehmet Akif Suludere; Jamie Monica Alberga; Gwenny Verstappen; Bert van der Vegt; Marcel Nijland; Arjan Vissink; Hendrika Bootsma; Konstantina Delli
deleteShare
deleteSave
Insights gained from drug utilization research to improve safe clinical practice for children and adolescents in Denmark
deleteExpert Opinion on Drug Safety
IF3.1
delete2026-04-06
delete0
PREAI
deleteHelene Kildegaard; Anton Pottegård
deleteShare
deleteSave
Safe prescribing of antihypertensive drugs in the elderly and managing the risk of adverse events
deleteExpert Opinion on Drug Safety
IF3.1
delete2026-04-04
delete0
PREAI
deleteSiddhant Passey; Maheen Erum; Nandan Patel; Shrey Chopra; Hritvik Jain; Jagriti Jha; Tyler Kingma; Obada Kholoki; Ashwin Pillai; Sai Vikram Alampoondi Venkataramanan; Wilbert Aronow
deleteShare
deleteSave